Literature DB >> 9654876

Serum albumin: a prognostic indicator in patients with colorectal cancer.

S D Heys1, L G Walker, D J Deehan, O E Eremin.   

Abstract

Various prognostic factors for survival have been identified in patients with colorectal cancer. However, although it has been suggested that the pre-treatment serum albumin concentration is a prognostic indicator in certain malignant diseases (melanoma, prostate cancer, leukaemia), its value in patients with colorectal cancer remains unclear. This study investigated the prognostic value of serum albumin in this patient group. A total of 431 patients presenting to the Professorial Surgical Unit between 1972 and 1985 were analysed in this study. Using the Cox proportional hazard model, age, tumour stage (Dukes' stage) and tumour differentiation were shown to be independent prognostic factors for survival in patients with localized colorectal cancer. In addition, the pre-treatment serum albumin concentration was found to be an independent prognostic indicator. This is the first such documentation for patients with 'curable' colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654876

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  42 in total

1.  Lower albumin levels in African Americans at colon cancer diagnosis: a potential explanation for outcome disparities between groups?

Authors:  Aja S McCutchen; Juan Carlos Munoz; Lacie Brenner; Peter Wludyka; Kenneth J Vega
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.

Authors:  Ryuma Tokunaga; Yasuo Sakamoto; Shigeki Nakagawa; Daisuke Izumi; Keisuke Kosumi; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2017-02-17       Impact factor: 3.402

3.  Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer.

Authors:  V Asher; J Lee; A Bali
Journal:  Med Oncol       Date:  2011-07-07       Impact factor: 3.064

4.  Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.

Authors:  Namrata Vijayvergia; Efrat Dotan; Karthik Devarajan; Kamel Hatahet; Farah Rahman; Julianna Ricco; Bianca Lewis; Sameer Gupta; Steven J Cohen
Journal:  J Geriatr Oncol       Date:  2015-08-18       Impact factor: 3.599

5.  Preoperative hypoalbuminemia is an independent risk factor for increased high-grade morbidity after elective rectal cancer resection.

Authors:  J Hardt; L Pilz; J Magdeburg; P Kienle; S Post; R Magdeburg
Journal:  Int J Colorectal Dis       Date:  2017-08-19       Impact factor: 2.571

6.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

7.  C-reactive protein, lipid-soluble micronutrients, and survival in colorectal cancer patients.

Authors:  Robert V Cooney; Weiwen Chai; Adrian A Franke; Lynne R Wilkens; Laurence N Kolonel; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-15       Impact factor: 4.254

8.  The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers.

Authors:  Campbell S D Roxburgh; Jonathan M Salmond; Paul G Horgan; Karin A Oien; Donald C McMillan
Journal:  J Gastrointest Surg       Date:  2009-09-19       Impact factor: 3.452

Review 9.  Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?

Authors:  Bassel Nazha; Elias Moussaly; Mazen Zaarour; Chanudi Weerasinghe; Basem Azab
Journal:  World J Gastrointest Surg       Date:  2015-12-27

10.  Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.

Authors:  Li-Chu Sun; Koung-Shing Chu; Su-Chen Cheng; Chien-Yu Lu; Chao-Hung Kuo; Jan-Sing Hsieh; Ying-Ling Shih; Shun-Jen Chang; Jaw-Yuan Wang
Journal:  BMC Cancer       Date:  2009-08-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.